Guided Therapeutics (GTHP) Intangibles (2010 - 2011)
Guided Therapeutics' (GTHP) quarterly Intangibles came in at $409000.0 in Q2 2011, up 36.79% quarter-over-quarter from $299000.0 in Q4 2010.
Analysis
Guided Therapeutics (GTHP) Intangibles (2010 - 2011) Analysis & Trends
Guided Therapeutics has disclosed Intangibles across 2 years of filings, most recently posting $409000.0 for Q2 2011.
- In Q2 2011, Intangibles changed N/A year-over-year to $409000.0; the TTM figure through Jun 2011 stood at $409000.0 (changed N/A YoY), while the FY2010 annual figure was $299000.0, changed N/A from the prior year.
- Intangibles came in at $409000.0 for Q2 2011 at Guided Therapeutics, up from $299000.0 in the prior quarter.
- In the past five years, Intangibles ranged from a high of $409000.0 in Q2 2011 to a low of $299000.0 in Q4 2010.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 17.21 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 1.14 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 10.24 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 5.74 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 6.92 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 1.38 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 8.27 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 101.60 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 1.56 Bn |
| 10 | Guided Therapeutics | 19.31 Mn | 19.30 Mn | - | - |